Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma

Oral Oncology

Volumn 44, Issue 7, 2008, Pages 703-709

  Lu, Jiade Jay ^a   Kong, Lin ^b   Shakespeare, Thomas P ^a,c   Loh, Kwok Seng ^a   Zhang, Qing ^a,d   Luke Tan, Kim Siang ^a   Lee, Khai Mun ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b FUDAN UNIVERSITY   (China)

^c North Coast Cancer Institute   (Australia)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Accelerated concomitant boost radiotherapy; Nasopharyngeal cancer; Radiation therapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DISTANT METASTASIS; FEMALE; HUMAN; MALE; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 45249115475     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.09.005     Document Type: Article

References (27)

1. In: Fleming I.D., Cooper J.S., Henson D.E., et al. (Eds). AJCC cancer staging manual. second ed. (1997), Lippincott-Raven, Philadelphia, PA 31-39
2. Cooper J.S., Cohen R., and Stevens R.E. A comparison of staging systems for nasopharyngeal carcinoma. Cancer 83 (1998) 213-219
3. Ozyar E., Yildiz F., Akyol F., et al. Comparison of AJCC 1988 and 1997 classification for nasopharyngeal carcinoma: American Joint Committee on Cancer. Int J Radiat Oncol Biol Phys 44 (1999) 1079-1087
4. Mesic J.B., Flether G.H., and Goepfert H. Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys 7 (1981) 447-453
5. Lee A.W.M., Law S.C.K., Foo W., et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 23 (1992) 261-272
6. Yang T.S., Ng K.T., Wang H.M., et al. Prognostic factors of locoregionally recurrent nasopharyngeal carcinoma - a retrospective review of 182 cases. Am J Clin Oncol 19 (1996) 337-343
7. Fu K.K., Pajak T.F., Trotti A., et al. A Radiotherapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma: first report of RTOG n9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
8. Wolden S.L., Zelefsky M.J., Kraus D.H., et al. Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol 19 (2001) 1105-1110
9. Fischer M., Stuben G., Klahold M., et al. Accelerated hyperfractionated radiotherapy with concurrent chemotherapy in locally advanced nasopharyngeal carcinoma: A phase II study. J Cancer Res Clin Oncol 127 (2001) 507-511
10. Jian J.M., Cheng S.H., and Tsai S.Y.C. Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 53 (2002) 344-352
11. Lu J.J., Shakespeare T.P., Thiagarajan A., et al. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity. Laryngoscope 115 (2005) 806-810
12. Ma X., Lu J.J., Loh K.S., et al. nasopharyngeal carcinoma: an evaluation of response and toxicity. Laryngoscope 116 12 (2006) 2162-2165
13. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
14. Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10 (1989) 1-10
15. Geara F.B., Sanguineti G., Tucker S.L., et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother Oncol 43 (1997) 53-61
16. Al-Saraf M., LeBlanc M., Giri P.G., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099. J Clin Oncol 16 (1998) 1310-1317
17. Skye H.C., Tsai S.Y.C., Yen L., et al. Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma. J Clin Oncol 18 (2000) 2040-2045
18. Teo P.M., Shiu W., Leung S.F., et al. Prognostic factors in nasopharyngeal carcinoma investigated by computer tomography: an analysis of 659 patients. Radiother Oncol 23 (1992) 79-93
19. Lee A.W.M., Chan D.K.K., Fowler J.F., et al. T1 nasopharyngeal carcinoma: the effect of waiting time on tumor control. Int J Radiat Oncol Biol Phys 30 5 (1994) 1111-1117
20. Teo P.M., Leung S.F., Chan A.T., et al. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys 48 (2000) 1311-1322
21. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 44 (1997) 111-121
22. Lee N., Xia P., Quivey J.M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSD experience. Int J Radiat Oncol Biol Phys 53 (2002) 12-22
23. Wolden S.L., Chen W.C., Pfister D.G., et al. Intensity-modulated radiation therapy (IMRT) for nasopharyngeal cancer: Update of the Memorial Sloan Kettering experience. Int J Radiat Oncol Biol Phys 64 (2006) 57-62
24. Hsiung C.Y., Yorke E.D., Chui C.S., et al. Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage therapy of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 53 (2002) 638-647
25. Kwong D.L.W., Sham J.S.T., Leung L.H.T., et al. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal cancer. Int J Radiat Oncol Biol Phys 64 2 (2006) 374-381
26. Marks J.E., Bedwinek J.M., Lee F., et al. Dose-response analysis for nasopharyngeal carcinoma: an historical perspective. Cancer 50 (1982) 1042-1050
27. Cao J., Zhou J., Zhou X., et al. Status of radiotherapy in China. Radiat Med 22 1 (2004) 9-11